Werbung
Werbung
CORT
Corcept Therapeutics Inc.
37.50
USDGesponsert
+0.97
+2.65%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
37.19
-0.31
-0.83%
CORT Ergebnisberichte
Positives Überraschungsverhältnis
CORT übertreffen die 26 der letzten 40Schätzungen.
65%
Nächster Bericht
Datum des nächsten Berichts
24. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$266.35M
/$0.34
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+28.28%
/+112.50%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+46.43%
/+30.77%
Corcept Therapeutics Inc. earnings per share and revenue
On 04. Nov. 2025, CORT reported earnings of 0.16 USD per share (EPS) for Q3 25, beating the estimate of 0.13 USD, resulting in a 16.19% surprise. Revenue reached 207.64 million, compared to an expected 222.90 million, with a -6.85% difference. The market reacted with a +7.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 0.34 USD, with revenue projected to reach 266.35 million USD, implying an increase of 112.50% EPS, and increase of 28.28% in Revenue from the last quarter.
FAQ
What were Corcept Therapeutics Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Corcept Therapeutics Inc. reported EPS of $0.16, beating estimates by 16.19%, and revenue of $207.64M, -6.85% below expectations.
How did the market react to Corcept Therapeutics Inc.'s Q3 2025 earnings?
The stock price moved up 7.81%, changed from $71.10 before the earnings release to $76.65 the day after.
When is Corcept Therapeutics Inc. expected to report next?
The next earning report is scheduled for 24. Feb. 2026.
What are the forecasts for Corcept Therapeutics Inc.'s next earnings report?
Based on 8
analysts, Corcept Therapeutics Inc. is expected to report EPS of $0.34 and revenue of $266.35M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung